Dhavalkumar Dhirajlal Patel
EVP, Chief Scientific Officer · 1 filing · Latest: Aug 26, 2026
Sana Biotechnology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SANA | Dhavalkumar Dhirajlal Patel | EVP, Chief Scientific Officer | Aug 26, 2026 | Option Exercise | $0.00 | 125,000 | — | 224,510 |